VOLUME 3, ISSUE 2, 2022 (JULY – DECEMBER)
Contents
Editorial
Hepatobiliary disease in the COVID-19 era
Juan Carlos Restrepo-Gutiérrez
Review articles
Cardiomyopathy in patients with liver cirrhosis: review article
Esteban González-Domínguez, Diego Córdova, Paula Abad, Eduardo González, Camila González, Juan José Cordero
Hepatobiliary disease associated with COVID-19
Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya
Conventional and emerging therapies in primary biliary cholangitis
Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez
Hyperbilirubinemia: pathologist's view
Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio
Original articles
Histological liver changes caused by chronic intake of monosodium glutamate
Ana Patricia Fabro, María del Carmen Contini, Noelia Villafañe, Adriana Benmelej
Primary biliary cholangitis: characterization of a retrospective cohort
Edgar Fernando Ayala-Sierra, Octavio G. Muñoz-Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo
Case reports
Hepatic hydrothorax as a rare complication of cirrhosis. A therapeutic challenge in advanced cirrhosis
Melissa Lara-Viáfara, Mauricio Salazar-Moreno, Juliana Suárez-Correa, Oscar Reyna-Carrasco
Sclerosing cholangitis associated with severe infection by SARS-CoV-2
Natalia Torres-Vellojín, Juan Camilo Díaz-Duque, Luz Adriana Gómez-Ramírez, Octavio G. Muñoz-Maya
Esta revista está bajo licencia internacional
Creative Commons Reconocimiento
NoComercial-SinObrasDerivadas 4.0.
